|
Roche Loses on Appeal of Boniva Patent Setback
Roche has been hit with a series of litigation setbacks as companies try to chip away at the exclusivity of Boniva, a once-monthly osteoporosis treatment.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives